Clinical Trials List
Protocol Number3066A1-303-WW
Not yet recruiting
Phase III
-
Trial Applicant
Wyeth-Ayerst (Asia) LLC
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
Co-Principal Investigator
Principal Investigator
Co-Principal Investigator
- Hsien-Kun Chang Division of Hematology & Oncology
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
1236 participants
